Exon architecture controls mRNA m<sup>6</sup>A suppression and gene expression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36705538.
- Also identified by DOI 10.1126/science.abj9090 and PMC identifier 9990141.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
<i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m<sup>6</sup>A (MPm<sup>6</sup>A), we discover that m<sup>6</sup>A specificity is globally regulated by suppressors that prevent m<sup>6</sup>A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m<sup>6</sup>A suppressors that protect exon junction-proximal RNA within coding sequences from methylation and regulate mRNA stability through m<sup>6</sup>A suppression. EJC suppression of m<sup>6</sup>A underlies multiple global characteristics of mRNA m<sup>6</sup>A specificity, with the local range of EJC protection sufficient to suppress m<sup>6</sup>A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.
Medical subject headings
- Exons
- RNA Splicing
- RNA, Messenger
- Gene Expression Regulation